Literature DB >> 2989764

Adenoviral diseases in children: a study of 105 hospital cases.

O Ruuskanen, O Meurman, H Sarkkinen.   

Abstract

The clinical findings for 105 children hospitalized with adenoviral infection were studied prospectively. In 82 children, the diagnosis was based on the detection of adenovirus antigen in the nasopharyngeal specimens and in 17 children in the feces. In the remaining six patients, findings from nasopharyngeal specimens were negative but a significant increase in CF (complement fixation) titers was detected. The clinical picture of adenoviral infection was characterized by high-grade (mean 39.4 degrees C) and prolonged fever (mean duration 5.4 days). Tonsillitis, otitis, and gastroenteritis were the most common illnesses. In 17% of the patients, no identifiable focus of infection could be demonstrated; nine children with no identifiable focus of infection had febrile convulsions. The WBC count and ESR varied from normal values to values seen in bacterial infections; thus it was difficult to distinguish adenoviral disease from a bacterial disease. Forty-five children were referred to the hospital due to infection unresponsive to antimicrobial therapy. The rapid detection of adenovirus antigen in nasopharyngeal specimens or feces proved to have a great clinical value in the diagnosis of adenoviral infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989764

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

1.  Concomitant respiratory viral infections in children with Kawasaki disease.

Authors:  Alejandro Jordan-Villegas; Michael L Chang; Octavio Ramilo; Asunción Mejías
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

2.  Clinical and laboratory findings in children with adenovirus infections.

Authors:  S Van Lierde; L Corbeel; E Eggermont
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

3.  Aplastic anaemia complicating adenovirus infection in DiGeorge syndrome.

Authors:  J Tuvia; B Weisselberg; I Shif; G Keren
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

4.  Adenovirus infection in families.

Authors:  O Ruuskanen; J Mertsola; O Meurman
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

5.  Pediatric Respiratory Virus Infections During the COVID-19 Pandemic in a Region Without Active Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Circulation.

Authors:  Sosuke Kakee; Yoichi Mino; Keisuke Okuno; Daisuke Kawaba; Atsushi Maejima; Noriyuki Namba
Journal:  Yonago Acta Med       Date:  2022-08-29       Impact factor: 1.371

6.  Detection of viruses in young children with fever without an apparent source.

Authors:  Joshua M Colvin; Jared T Muenzer; David M Jaffe; Avraham Smason; Elena Deych; William D Shannon; Max Q Arens; Richard S Buller; Wai-Ming Lee; Erica J Sodergren Weinstock; George M Weinstock; Gregory A Storch
Journal:  Pediatrics       Date:  2012-11-05       Impact factor: 7.124

7.  Clinical Impact of Mixed Respiratory Viral Infection in Children with Adenoviral Infection.

Authors:  Hyun Jun Lee; Young Eun Seo; Seung Beom Han; Dae Chul Jeong; Jin Han Kang
Journal:  Infect Chemother       Date:  2016-11-21

8.  Serum Inflammatory Markers in Patients with Adenovirus Respiratory Infection.

Authors:  Junping Sun; Yongjiu Xiao; Mingyue Zhang; Ting Ao; Shan Lang; Jianxin Wang
Journal:  Med Sci Monit       Date:  2018-06-07

9.  Hematological and biochemical factors predicting SARS fatality in Taiwan.

Authors:  Hsiao-Ling Chang; Kow-Tong Chen; Shu-Kuan Lai; Hung-Wei Kuo; Ih-Jen Su; Ruey S Lin; Fung-Chang Sung
Journal:  J Formos Med Assoc       Date:  2006-06       Impact factor: 3.282

10.  Clinical manifestations of respiratory adenoviral infection among hospitalized children in Korea.

Authors:  Hyo Jin Kwon; Young Jun Rhie; Won Hee Seo; Gi-Young Jang; Byung Min Choi; Jung Hwa Lee; Chang-Kyu Lee; Yun Kyung Kim
Journal:  Pediatr Int       Date:  2013-08       Impact factor: 1.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.